NEW YORK (GenomeWeb) – NeoGenomics has commenced an underwritten public offering of approximately $125 million of newly issued shares of common stock.

The company intends to grant underwriters a 30-day option to purchase up to an aggregate of an additional 15 percent of the shares offered in the public offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.